Cesarean Delivery Completed Phase 2 Trials for Misoprostol (DB00929)

IndicationStatusPhase
DBCOND0036001 (Cesarean Delivery)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01466530Sublingual Misoprostol & Isoflurane During Caesarean SectionPrevention